How To Use CPT Code 90685

CPT 90685 describes the administration of a preservative-free, quadrivalent influenza virus vaccine in a 0.25 mL dose for intramuscular use. This article will cover the description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, similar codes and billing examples.

1. What is CPT Code 90685?

CPT 90685 is used to describe the administration of a preservative-free, quadrivalent influenza virus vaccine in a 0.25 mL dose for intramuscular use. This vaccine is designed to provide immunity against four different strains of the influenza virus, a severe and infectious respiratory disease.

2. Official Description

The official description of CPT code 90685 is: ‘Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use.’

3. Procedure

1. The healthcare provider prepares the patient for the administration of the influenza vaccine.
2. A preservative-free, quadrivalent influenza virus vaccine in a 0.25 mL dose is administered into the muscle of the patient.
3. The vaccine provides immunity against four different strains of the influenza virus.
4. The patient may experience potential side effects, and the healthcare provider should provide instructions and precautions before administering the vaccine.

4. Qualifying circumstances

CPT 90685 is appropriate for patients who require immunization against the influenza virus. It is important to note that this code specifically refers to the administration of the preservative-free, quadrivalent influenza virus vaccine in a 0.25 mL dose for intramuscular use.

5. When to use CPT code 90685

CPT code 90685 should be used when a healthcare provider administers the preservative-free, quadrivalent influenza virus vaccine in a 0.25 mL dose for intramuscular use. It is important to ensure that the vaccine administered matches the description provided in the code.

6. Documentation requirements

To support a claim for CPT 90685, the healthcare provider must document the following information:

• The administration of the preservative-free, quadrivalent influenza virus vaccine in a 0.25 mL dose
• The date and time of the administration
• Any potential side effects experienced by the patient
• Instructions and precautions provided to the patient

7. Billing guidelines

When billing for CPT 90685, ensure that the healthcare provider administers the preservative-free, quadrivalent influenza virus vaccine in a 0.25 mL dose for intramuscular use. It is important to follow the specific guidelines for reporting this code and to include the necessary documentation to support the claim.

8. Historical information

CPT 90685 was added to the Current Procedural Terminology system on January 1, 2014. There have been some historical changes to the code, including updates to the description and qualifying circumstances.

9. Examples

1. A healthcare provider administers the preservative-free, quadrivalent influenza virus vaccine in a 0.25 mL dose to a patient to protect against four different strains of the influenza virus.
2. A nurse prepares a patient for the administration of the preservative-free, quadrivalent influenza virus vaccine in a 0.25 mL dose for intramuscular use.
3. A healthcare provider discusses the risks and benefits of the preservative-free, quadrivalent influenza virus vaccine with a patient before administering it in a 0.25 mL dose.
4. A pharmacist administers the preservative-free, quadrivalent influenza virus vaccine in a 0.25 mL dose to a patient to provide immunity against four different strains of the influenza virus.
5. A healthcare provider documents the administration of the preservative-free, quadrivalent influenza virus vaccine in a 0.25 mL dose for intramuscular use in a patient’s medical record.
6. A nurse educates a patient about the potential side effects of the preservative-free, quadrivalent influenza virus vaccine before administering it in a 0.25 mL dose.
7. A healthcare provider ensures that the preservative-free, quadrivalent influenza virus vaccine is stored properly before administering it in a 0.25 mL dose to a patient.
8. A pharmacist reviews the patient’s medical history to determine if the preservative-free, quadrivalent influenza virus vaccine in a 0.25 mL dose is appropriate for them.
9. A healthcare provider explains the purpose and benefits of the preservative-free, quadrivalent influenza virus vaccine in a 0.25 mL dose to a patient before administering it.
10. A nurse administers the preservative-free, quadrivalent influenza virus vaccine in a 0.25 mL dose to a patient and provides them with aftercare instructions.